The FDA has given emergency authorization to treat Covid-19 patients with convalescent plasma, which is made using blood from people who have recovered from coronavirus infections. The decision comes after President Donald Trump had been pressuring the agency to move faster. The FDA says convalescent plasma has been used to treat more than 70,000 Covid-19 patients and that the “known and potential benefits of the product outweigh the known and potential risks.” But while early studies have shown some promise, some health experts argue data from randomized, placebo-controlled clinical trials…
Read MoreCOVID-19: FDA AUTHORISES CONVALESCENT PLASMA AS EMERGENCY TREATMENT
